Lindbrook Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Lindbrook Capital’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-243	Closed	-$13K	–	3074
2022 Q3	$13K	Buy	243 +116	+91%	+$4.79K	﹤0.01%	1223
2022 Q2	$3K	Buy	127 +69	+119%	+$1.52K	﹤0.01%	1883
2022 Q1	$1K	Buy	58 +22	+61%	+$618	﹤0.01%	2443
2021 Q4	$1K	Hold	36	–	–	﹤0.01%	2043
2021 Q3	$1K	Buy	+36	New	+$561	﹤0.01%	1825
2019 Q2	–	Sell	-750	Closed	-$10K	–	1542
2019 Q1	$10K	Buy	+750	New	+$8.58K	﹤0.01%	909

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's CCXI Position: Q4 2022 in Review

Lindbrook Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 243 shares — an estimated $13K sold.

Lindbrook Capital first reported a position in CCXI in Q1 2019 and held it in 6 quarters. The position peaked at $13K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Lindbrook Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Lindbrook Capital sold 243 ChemoCentryx, Inc. shares in Q4 2022, an estimated $13K.
Lindbrook Capital first reported a position in ChemoCentryx, Inc. in Q1 2019 and held it in 6 quarters.
Lindbrook Capital's ChemoCentryx, Inc. position peaked at $13K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Lindbrook Capital's 13F filing for Q4 2022, filed 25 Jan 2023.